Cookie Policy

By clicking "Accept", you are agreeing to continue browsing and accept the website privacy policy.

Responsive image

Drug Information

Drug Generic Name BICALUTAMIDE
Drug Class ANTIANDROGEN
Chapter Malignant Disease & Immunosuppression

Indications: Treatment of metastatic prostate cancer (in combination with an LHRH agonist).

Cautions: consider periodic liver function tests

Contra-indications: Hypersensitivity to bicalutamide or any component of the formulation; use in women, especially women who are or may become pregnant.

Side Effects: nausea, diarrhoea, cholestasis, jaundice; asthenia, weight gain; gynaecomastia, breast tenderness, hot flushes, impotence, decreased libido; anaemia; alopecia, dry skin, hirsutism, pruritus; less commonly vomiting, abdominal pain, dyspepsia, interstitial lung disease, pulmonary fibrosis, depression, haematuria, thrombocytopenia, hypersensitivity reactions including angioneurotic oedema and urticaria; rarely cardiovascular disorders (including angina, heart failure, and arrhythmias), and hepatic failure.

Dose: Locally advanced prostate cancer at high risk of disease progression: 150 mg once daily locally advanced, non-metastatic prostate cancer when surgical castration or other medical intervention inappropriate: 150 mg once daily. Advanced prostate cancer: in combination with gonadorelin analogue or surgical castration, 50 mg once daily.

Brand Name
  • Casodex Tablets 50 mg
rating - 1 starrating - 2 starrating - 3 starrating - 4 starrating - 5 star 0 (0 Votes)